Market News & Reports | Win Wind Capital

Market News & Reports

Monday to Friday

8:30AM - 5:30PM

Saturday, Sunday & Public Holidays

Closed

Hotline:

(852)3198-0622

Online Enquiry:

IPO Basic

Symbol	Name	Industry	Offering Price	Lot Size	Entry Fee	Forecast P/E	Offering Date	Listing Date
02561.HK	VISEN Pharma-B	Biotechnology - Pharmaceuticals	HKD 68.44 - 75.28	100	7,604	N/A	2025/03/13- 2025/03/18	2025/03/21

VISEN Pharmaceuticals-B (02561.HK)

Financial Comparison - Annual Results	2023/12	2022/12
Liquidity Analysis	VISEN Pharma	VISEN Pharma	Average
Current Ratio (X)	7.22	8.15	7.69
Quick Ratio (X)	7.22	8.15	7.69
Solvency Analysis
Long Term Debt/Equity (%)	0.28	0.20	0.24
Total Debt/Equity (%)	0.93	0.92	0.93
Total Debt/Capital Employed (%)	0.93	0.92	0.93
Return on Investment Analysis
Return on Equity (%)	N/A	N/A	N/A
Return on Capital Employ (%)	N/A	N/A	N/A
Return on Total Assets (%)	N/A	N/A	N/A
Profitability Analysis
Operating Profit Margin (%)	N/A	N/A	N/A
Pre-tax Profit Margin (%)	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A
Trading Analysis
Inventory Turnover (X)	0	0	0.00
Investment Income Analysis
Dividend Payout (%)	0.00	0.00	0.00
Related Statistics
Fiscal Year High	N/A	N/A	N/A
Fiscal Year Low	N/A	N/A	N/A
Fiscal Year PER Range High (X)	N/A	N/A	N/A
Fiscal Year PER Range Low (X)	N/A	N/A	N/A
Fiscal Year Yield Range High (%)	0.00	0.00	N/A
Fiscal Year Yield Range Low (%)	0.00	0.00	N/A

*Information is delayed for at least 15 mins

Information from the financial statements of listed companies

Last Update: 2025/03/14

Information provided by AASTOCKS